These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 1695120)
21. Serum sex hormone-binding globulin and osteocalcin in systemic nonthyroidal illness associated with low thyroid hormone concentrations. Seppel T; Becker A; Lippert F; Schlaghecke R J Clin Endocrinol Metab; 1996 Apr; 81(4):1663-5. PubMed ID: 8636386 [TBL] [Abstract][Full Text] [Related]
22. Stability of free and total prostate specific antigen in serum from patients with prostate carcinoma and benign hyperplasia. Paus E; Nilsson O; Børmer OP; Fosså SD; Otnes B; Skovlund E J Urol; 1998 May; 159(5):1599-605. PubMed ID: 9554362 [TBL] [Abstract][Full Text] [Related]
23. Human sperm sex hormone-binding globulin isoform: characterization and measurement by time-resolved fluorescence immunoassay. Selva DM; Bassas L; Munell F; Mata A; Tekpetey F; Lewis JG; Hammond GL J Clin Endocrinol Metab; 2005 Nov; 90(11):6275-82. PubMed ID: 16131577 [TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia. Ho PJ; Baxter RC Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044 [TBL] [Abstract][Full Text] [Related]
25. Prostatic distribution of sex hormone-binding globulin and cortisol-binding globulin in benign hyperplasia. Cowan RA; Cowan SK; Giles CA; Grant JK J Endocrinol; 1976 Oct; 71(1):121-31. PubMed ID: 62006 [TBL] [Abstract][Full Text] [Related]
26. Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma: a longitudinal study. Heikkilä R; Aho K; Heliövaara M; Hakama M; Marniemi J; Reunanen A; Knekt P Cancer; 1999 Jul; 86(2):312-5. PubMed ID: 10421267 [TBL] [Abstract][Full Text] [Related]
27. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683 [TBL] [Abstract][Full Text] [Related]
28. High serum sex hormone-binding globulin (SHBG) and low serum non-SHBG-bound testosterone in boys with idiopathic hypopituitarism: effect of recombinant human growth hormone treatment. Belgorosky A; Martinez A; Domene H; Heinrich JJ; Bergada C; Rivarola MA J Clin Endocrinol Metab; 1987 Dec; 65(6):1107-11. PubMed ID: 3680477 [TBL] [Abstract][Full Text] [Related]
29. Serum pituitary and sex steroid hormone levels in the etiology of prostatic cancer--a population-based case-control study. Andersson SO; Adami HO; Bergström R; Wide L Br J Cancer; 1993 Jul; 68(1):97-102. PubMed ID: 8318428 [TBL] [Abstract][Full Text] [Related]
30. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia. Ho PJ; Baxter RC Clin Endocrinol (Oxf); 1997 Feb; 46(2):145-54. PubMed ID: 9135695 [TBL] [Abstract][Full Text] [Related]
31. Low 25-OH vitamin D is associated with benign prostatic hyperplasia. Haghsheno MA; Mellström D; Behre CJ; Damber JE; Johansson H; Karlsson M; Lorentzon M; Peeker R; Barret-Connor E; Waern E; Sundh V; Ohlsson C; Hammarsten J J Urol; 2013 Aug; 190(2):608-14. PubMed ID: 23399651 [TBL] [Abstract][Full Text] [Related]
33. Sex hormone-binding globulin is an independent predictor of biochemical recurrence after radical prostatectomy. Waldert M; Schatzl G; Swietek N; Rom M; Klatte T J Urol; 2012 Sep; 188(3):792-7. PubMed ID: 22818139 [TBL] [Abstract][Full Text] [Related]
34. The Pro12Ala polymorphism of the PPAR gamma 2 gene influences sex hormone-binding globulin level and its relationship to the development of the metabolic syndrome in young Finnish men. Mousavinasab F; Tähtinen T; Jokelainen J; Koskela P; Vanhala M; Oikarinen J; Laakso M; Keinänen-Kiukaanniemi S Endocrine; 2006 Oct; 30(2):185-90. PubMed ID: 17322577 [TBL] [Abstract][Full Text] [Related]
35. The relationship between serum levels of insulin and sex hormone-binding globulin in men: the effect of weight loss. Strain G; Zumoff B; Rosner W; Pi-Sunyer X J Clin Endocrinol Metab; 1994 Oct; 79(4):1173-6. PubMed ID: 7962291 [TBL] [Abstract][Full Text] [Related]
36. Circulating testosterone, prostatic nuclear androgen receptor and time to progression in patients with metastatic disease of the prostate treated by orchiectomy. van Aubel OG; Bolt-de Vries J; Blankenstein MA; de Jong FH; Schröder FH Urol Res; 1989; 17(2):99-102. PubMed ID: 2734984 [TBL] [Abstract][Full Text] [Related]
37. Effects of diet and exercise on insulin, sex hormone-binding globulin, and prostate-specific antigen. Tymchuk CN; Tessler SB; Aronson WJ; Barnard RJ Nutr Cancer; 1998; 31(2):127-31. PubMed ID: 9770724 [TBL] [Abstract][Full Text] [Related]
38. [Plasma testosterone and sex hormone transport globulin in patients with prostatic carcinoma under treatment]. Daponte DP; Pidcock M; Robinson MR; Smith PH Actas Urol Esp; 1982; 6(1):17-20. PubMed ID: 7200715 [No Abstract] [Full Text] [Related]
39. Reference intervals for serum sex hormones in Han Chinese adult men from the Fangchenggang Area Male Health and Examination Survey. Qin X; Lv H; Mo Z; Chen Z; Lin L; Peng T; Zhang H; Yang X; Gao Y; Tan A; Huang S; Li H; Wu H; Deng Y; Li S Clin Lab; 2012; 58(3-4):281-90. PubMed ID: 22582502 [TBL] [Abstract][Full Text] [Related]
40. Reference Ranges and Association of Age and Lifestyle Characteristics with Testosterone, Sex Hormone Binding Globulin, and Luteinizing Hormone among 1166 Western Chinese Men. Shen X; Wang R; Yu N; Shi Y; Li H; Xiong C; Li Y; Wells EM; Zhou Y PLoS One; 2016; 11(10):e0164116. PubMed ID: 27711240 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]